Study of Octagam 10% on the Treatment of Mild to Moderate Alzheimer's Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Octapharma
ClinicalTrials.gov Identifier:
NCT00812565
First received: November 10, 2008
Last updated: May 6, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
No publications provided by Octapharma

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):